The CD8 Antiviral Factor (CAF) can suppress HIV-1 transcription from the Long Terminal Repeat (LTR) promoter in the absence of elements upstream of the CATATAA box

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Shridhar, Varsha ^a,b   Chen, Yue ^b   Gupta, Phalguni ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

CD8 antiviral factor; HIV 1; Long Terminal Repeat; Transcription suppression

Indexed keywords

CD8 ANTIVIRAL FACTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MESSENGER RNA; PROTEIN; PROTEIN BINDING;

ARTICLE; BINDING SITE; CATATAA BOX; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA STRUCTURE; GENE DELETION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MTT ASSAY; NONHUMAN; POINT MUTATION; PROMOTER REGION; PROTEIN DNA INTERACTION; REPORTER GENE; TATA BOX; VIRUS TRANSCRIPTION; CD4+ T LYMPHOCYTE; CELL LINE; CONFORMATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; TRANSCRIPTION INITIATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEINS; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84904447425     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-130     Document Type: Article

References (35)

1. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Walker CM, Moody DJ, Stites DP, Levy JA, Science 1986 234 4783 1563 1566
2. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P, Science 1995 270 5243 1811 1815
3. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Levy JA, Mackewicz CE, Barker E, Immunol Today 1996 17 5 217 224
4. CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. Chen CH, Weinhold KJ, Bartlett JA, Bolognesi DP, Greenberg ML, AIDS Res Hum Retroviruses 1993 9 11 1079 1086
5. CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. Mackewicz CE, Patterson BK, Lee SA, Levy JA, J Gen Virol 2000 81 Pt 5 1261 1264
6. CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Tomaras GD, Lacey SF, McDanal CB, Ferrari G, Weinhold KJ, Greenberg ML, Proc Natl Acad Sci U S A 2000 97 7 3503 3508
7. Initiation of human immunodeficiency virus type 1 (HIV-1) transcription is inhibited by noncytolytic CD8 suppression. Overman RG, Llorens AL, Greenberg ML, Garcia-Blanco MA, Tomaras GD, Open Virol J 2007 1 1 7
8. Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD8+ T cells. Tumne A, Prasad VS, Chen Y, Stolz DB, Saha K, Ratner DM, Ding M, Watkins SC, Gupta P, J Virol 2009 83 9 4354 4364
9. HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication. Mackewicz CE, Garovoy MR, Levy JA, J Virol 1998 72 12 10165 10170
10. Role of class I major histocompatibility complex-restricted and -unrestricted suppression of human immunodeficiency virus type 1 replication by CD8+ T lymphocytes. Ohashi T, Kubo M, Kato H, Iwamoto A, Takahashi H, Fujii M, Kannagi M, J Gen Virol 1999 80 Pt 1 209 216
11. Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. Kannagi M, Chalifoux LV, Lord CI, Letvin NL, J Immunol 1988 140 7 2237 2242
12. Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. Castro BA, Walker CM, Eichberg JW, Levy JA, Cell Immunol 1991 132 1 246 255
13. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. Mackewicz CE, Ortega HW, Levy JA, J Clin Invest 1991 87 4 1462 1466
14. CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Walker CM, Thomson-Honnebier GA, Hsueh FC, Erickson AL, Pan LZ, Levy JA, Cell Immunol 1991 137 2 420 428
15. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Landay AL, Mackewicz CE, Levy JA, Clin Immunol Immunopathol 1993 69 1 106 116
16. CD8+ cells from HIV-2-infected baboons control HIV replication. Blackbourn DJ, Locher CP, Ramachandran B, Barnett SW, Murthy KK, Carey KD, Brasky KM, Levy JA, AIDS 1997 11 6 737 746
17. Suppression of human immunodeficiency virus type 1 replication by a soluble factor produced by CD8+ lymphocytes from HIV-2-infected baboons. Locher CP, Blackbourn DJ, Levy JA, Immunol Lett 1999 66 1-3 151 157
18. Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression. Dioszeghy V, Benlhassan-Chahour K, Delache B, Dereuddre-Bosquet N, Aubenque C, Gras G, Le Grand R, Vaslin B, J Virol 2006 80 1 236 245
19. Dependence of CD8+ T-cell-mediated suppression of HIV type 1 on viral phenotypes and mediation of phenotype-dependent suppression by viral envelope gene and not by beta-chemokines. Chen Y, Dampf D, Chen M, Kulka K, Volsky DJ, Saha K, Gupta P, AIDS Res Hum Retroviruses 2000 16 2 117 124
20. Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines. Geiben-Lynn R, Kursar M, Brown NV, Kerr EL, Luster AD, Walker BD, J Virol 2001 75 17 8306 8316
21. Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV responses: the role of IL15. Castelli J, Thomas EK, Gilliet M, Liu Y-J, Levy JA, Blood 2004 103 2699 2704
22. Co-receptor antagonists as HIV-1 entry inhibitors. Shaheen FCRG, Curr Opin Infect Dis 2004 17 1 7 16
23. Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages. Mosoian A, Teixeira A, High AA, Christian RE, Hunt DF, Shabanowitz J, Liu X, Klotman M, J Virol 2006 80 18 9200 9206
24. Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of beta chemokines and RNases. Cocchi F, DeVico AL, Lu W, Popovic M, Latinovic O, Sajadi MM, Redfield RR, Lafferty MK, Galli M, Garzino-Demo A, Gallo RC, Proc Natl Acad Sci U S A 2012 109 14 5411 5416
25. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M, Science 2007 315 5818 1579 1582
26. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response. Bonneau KR, Ng S, Foster H, Choi KB, Berkhout B, Rabson A, Mackewicz CE, Levy JA, Virology 2008 373 1 30 38
27. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Southgate CD, Green MR, Genes Dev 1991 5 12B 2496 2507
28. Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure. Delling U, Reid LS, Barnett RW, Ma MY, Climie S, Sumner-Smith M, Sonenberg N, J Virol 1992 66 5 3018 3025
29. Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains. Berkhout B, Jeang KT, Nucleic Acids Res 1991 19 22 6169 6176
30. Role of RNA structure in arginine recognition of TAR RNA. Puglisi JD, Chen L, Frankel AD, Williamson JR, Proc Natl Acad Sci U S A 1993 90 8 3680 3684
31. HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, EMBO J 1990 9 12 4145 4153
32. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Laspia MF, Rice AP, Mathews MB, Cell 1989 59 2 283 292
33. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. Harrich D, Garcia J, Wu F, Mitsuyasu R, Gonazalez J, Gaynor R, J Virol 1989 63 6 2585 2591
34. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. Schafer SL, Vlach J, Pitha PM, J Virol 1996 70 10 6937 6946
35. Promoter influences transcription elongation: TATA-box element mediates the assembly of processive transcription complexes responsive to cyclin-dependent kinase 9. Montanuy I, Torremocha R, Hernandez-Munain C, Sune C, J Biol Chem 2008 283 12 7368 7378